A- A A+

Our Mission: to be the preeminent professional organization for multiple sclerosis (MS) healthcare providers and researchers in North America, and a valued partner in the global MS community. Our core purpose is to maximize the ability of MS healthcare professionals to impact care of people who are affected by MS, thus improving their quality of life.

 
IJMSC
NARCOMS
IOMSRT
Accredited regional programs are now available from CMSC.  read more...          Article: Running Out Of Time, Money, And Independence? by Michael Ogg  read more...
For a complete list of CMSC materials, please click on the menu below
Please click on the tabs on the left to read about the latest CMSC materials

HealthDay information

First Test Approved to Help Detect Risk of Rare Brain Infection

FRIDAY, Jan. 20 (HealthDay News) -- The first test to help determine the risk of a rare brain infection among users of the drug Tysabri has been approved by the U.S. Food and Drug Administration.

Tysabri (natalizumab) is commonly prescribed to treat multiple sclerosis or Crohn's disease. A relatively small number of users have developed a rare brain infection called progressive multifocal leukoencephalopathy (PML). The newly approved Stratify JCV Antibody ELISA test, combined with other clinical data, can help doctors evaluate the risk of developing PML among people who take Tysabri to treat MS or Crohn's, the FDA said in a news release.

There is "no treatment, prevention or cure for PML, and no certain way to predict who will develop it," the agency stressed. But it said risk factors for PML include the presence of antibodies for the John Cunningham virus, a normally harmless germ except among people with weakened or medically suppressed immune systems.

Other risk factors for developing PML, the FDA said, include taking Tysabri for at least two years, or taking other drugs that suppress the immune system.

The risk for developing PML, believed to be about 11 in 1,000, is greatest among people with all three risk factors, the agency said.

The newly approved test should not be used on its own to measure a person's risk of developing PML, nor should it be used to diagnose the rare infection, the FDA said.

The new test is manufactured by Focus Diagnostics, based in Cypress, Calif. Tysabri is co-marketed by Biogen Idec and Elan Corp.

More information

The FDA has more about Tysabri.

Archive

2011-12-30

Multiple Sclerosis May Cause Changes in Thalamus: Study

2011-12-07

MS May Take a Different Pathway Than Previously Thought

2011-11-01

New Multiple Sclerosis Therapy Promising in Early Trial

2011-10-17

Shift Work May Put Teens at Risk for Multiple Sclerosis

2011-10-05

Experimental MS Drug Shows Promise

2011-09-23

Many Black Men in Cold Climates Lack Vitamin D

2011-08-24

Botox Approved to Treat Urinary Incontinence

2011-08-10

Honing in on the Genetics of MS

2011-07-21

Are Newer MS Drugs Worth Their High Price Tag?

2011-07-06

Breast-Feeding May Not Protect Moms Against MS Relapse

2011-06-27

Pregnancy Safe for Most Women With MS: Study

2011-05-30

Stress Doesn't Boost Risk for Multiple Sclerosis

2011-05-24

MS in Blacks Linked to Low Vitamin D

2011-04-18

Health Tip: Understanding Autoimmune Diseases

2011-04-11

New Pill for MS Shows Promise in Clinical Trial

2011-03-28

Medical Marijuana Might Slow Thinking Among MS Patients

2011-03-21

Stem Cell Transplant May Help Aggressive MS: Study

2011-02-27

Higher Vitamin D Intake Could Cut Cancer Risk

2011-02-17

Warm Weather May Cloud Thinking in MS Patients

2011-02-15

Study Links MS to Brain Chemical Deficiency

2011-02-07

Low Sun Exposure, Vitamin D Levels May Be Tied to MS Risk

2011-01-31

New Oral Drugs Hailed for Treating MS

2011-01-18

Vein-Opening Treatment for MS Stirs Controversy

2011-01-17

Some Severe MS Flares Helped by Blood Filtering Treatment

2011-01-05

Study Sheds Light on Genetic Risk of MS

2010-12-08

How MS Affects Kids May Differ by Race

2010-10-01

Health Tip: Living With Multiple Sclerosis

2010-09-28

Meditation Soothes MS Patients

2010-09-23

Animal Studies Offer Insights Into MS

2010-09-22

Gilenya Approved for Relapsing MS

2010-09-13

Common Asthma Drug Could Speed MS Treatment

2010-09-01

Immune System Research Sees Many Similarities Among People

2010-08-30

Multiple Sclerosis Changes With the Seasons

2010-08-24

Vitamin D May Influence Genes for Cancer, Autoimmune Disease

2010-07-07

Brain Changes in MS May Spur Depression

2010-06-14

New Clues to Preventing Memory Loss From MS

2010-06-11

FDA Panel Endorses 1st Oral Drug for Multiple Sclerosis

2010-06-10

Eye Exam May Someday Spot Multiple Sclerosis

2010-05-09

Genetic Variants Tied to MS, Study Finds

2010-04-29

Sunlight May Play Role in Multiple Sclerosis Risk

2010-04-28

Twins Study Points to Environmental Cause for MS

2010-04-16

Cholesterol Drugs May Slow MS

2010-04-14

Treatment Eases Involuntary Laughing, Crying Tied to Alzheimer's, MS

2010-04-08

Vaccine Reverses Type 1 Diabetes in Mice

2010-04-07

Smoking May Boost MS Risk in Some

2010-03-29

Discovery May Lead to Better Multiple Sclerosis Treatments

2010-02-26

Reading Remediation Seems to Rewire the Brain

2010-02-24

Fitness Boosts Brain Power in Multiple Sclerosis Patients

2010-02-16

Added Drug Aids MS Treatment

2010-02-09

Drinking Milk While Pregnant May Lower Kids' MS Risk

2010-02-05

More Doses of MS Drug Raise Risk of Brain Infection

2010-01-22

Ampyra Approved for Adults With MS

2010-01-20

First Oral Medications For MS Show Promise

2010-01-19

Mouse Study May Advance Multiple Sclerosis Research

2009-12-04

Review Finds Marijuana May Help MS Patients

2009-11-24

Childbirth May Slow Progression of Multiple Sclerosis

2009-11-18

MS Need Not Preclude Pregnancy

2009-11-10

Teen Obesity Ups MS Risk in Women

2009-11-06

Early Relapse of MS May Mean Fewer Issues Later

2009-10-23

Light Touch Helps Grip of MS Patients

2009-10-06

Early Drug Treatment May Cut Multiple Sclerosis Risk

2009-09-11

Two Genes May Determine How Well MS Patients Do

2009-09-09

Scientists Find Clue to Dangerous Side Effect of MS Drug

2009-08-17

Extavia Approved for Multiple Sclerosis

2009-08-12

Scientists Reverse Multiple Sclerosis in Mice

2009-07-13

Smoking May Speed Multiple Sclerosis Symptoms

2009-06-26

Smoking May Trigger Brain Damage

2009-06-08

Breast-feeding OK for Most Moms with MS

2009-06-04

Herb May Offer Hope for Autoimmune Diseases

2009-05-22

Synthetic Vitamin A-Like Molecule Blocks Early MS

2009-05-04

Researcher IDs Narcolepsy as Autoimmune Disease

2009-04-30

Drug Combo May Relieve MS Symptoms

2009-04-28

Tysabri May Treat Myelin Sheath Damage From MS

2009-04-26

Fat-Derived Stem Cells Might Treat MS

2009-04-09

Stem Cell Breakthrough May Lead to MS Treatments

2009-04-03

Cat Food-Linked Illness Yields Clues to MS

2009-03-31

People With MS May Have Lower Cancer Risk

2009-02-27

Drug Improves Mobility in Some MS Patients

2009-02-05

Vitamin D Deficit May Trigger MS Risk Gene

2009-02-04

Leprosy Drug Holds Promise for Autoimmune Diseases

2009-01-29

Stem Cell Transplants Help MS Victims

2009-01-13

Pediatric MS Tied to Higher Relapse Rates

2008-12-10

MRI Can Spot Presymptomatic MS

2008-11-12

Only Half of MS Patients Respond to Interferon Therapy

2008-10-29

Other Health Problems Can Delay MS Diagnosis

2008-10-03

Protein in Spinal Fluid May Contribute to MS: Study

2008-09-30

Link Between Vaccine and MS Unproven

2008-09-19

Vitamin D Levels Might Predict Risk for MS

2008-09-19

Red Wine Molecule Might Battle MS

2008-09-05

FDA to List Drugs Under Review for Safety Issues

2008-08-01

Neurons Can Re-Grow in Some MS Lesions

MS News is brought to you by the Consortium of MS Centers as part of the eMS-Health Project funded by an unrestricted grant from Teva Neuroscience.

Copyright © 2008 ScoutNews, LLC. All rights reserved.